Regen BioPharma Inc (RGBP)

[Skiluc]

SAN FRANCISCO, CA / ACCESSWIRE / April 7, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) signed a license agreement with Regen BioPharma Inc. for intellectual property pertaining to mRNA to be used in developing a therapy for treating pancreatic cancer. This license agreement expands the Company's portfolio of intellectual property that It plans to develop for niche biotechnology markets.

Oncology Pharma issued a statement "We are looking to expand our presence in the cancer therapy market. This showcases our commitment to developing quality therapies to make patients lives better."

A spokesperson for the Company said the company believes this is a major milestone for the company and is evidence of it achieving its goals in brand development.